Aldeyra Therapeutics (ALDX) – Corporate News
-
Aldeyra Therapeutics (ALDX) Lays Out Clinical Development Plan for Resubmission of NDA for Reproxalap in Dry Eye Disease
-
Aldeyra Therapeutics (ALDX) Files $200M Mixed Shelf
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ALDX Stock Lookup